Company: RGNT
Filing Date: 2025-03-11
Form Type: F-1
Source: 0001213900-25-022350
Chunk: 249

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-03-11
Form: F-1
Chunk 249
---
 Company’s financial statements do not reflect any adjustments that might
result from the outcome of this uncertainty.

| d. | Impact of the “Iron Swords” War on Israel |

In October 2023, Hamas terrorists infiltrated
Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the
attack, Israel’s security cabinet declared war against Hamas and commenced a military campaign against Hamas and other terrorist
organizations in parallel to their continued rocket and terror attacks. In addition, Hezbollah have attacked military and civilian targets
in Northern Israel, to which Israel has responded, including through increased air and ground operations in Lebanon. Since the war broke
out, our operations have not been adversely affected by this situation, and we have not experienced disruptions to our development. However,
the intensity and duration of Israel’s current war against Hamas and Hezbollah is difficult to predict at this stage, as are such
war’s economic implications on the Company’s business and operations and on Israel’s economy in general. The Company
continues to monitor its ongoing activities and will make adjustments in its business if needed, including updating any estimates or
judgments impacting its financial statements as appropriate.

| NOTE 2: | SIGNIFICANT ACCOUNTING POLICIES |

| a. | Unaudited interim condensed financial statements: |

The accompanying interim condensed balance
sheet as of June 30, 2024, the interim condensed statements of comprehensive loss, temporary equity and shareholders’ deficit,
and cash flows for the six months ended June 30, 2024, and 2023, and the related notes to such interim condensed financial statements
are unaudited. These unaudited interim condensed financial statements have been prepared in accordance with U.S. generally accepted accounting
principles (“U.S. GAAP”) and are presented in accordance with the rules and regulations of the U.S. Securities and Exchange
Commission (“SEC”) and do not include all disclosures normally required in annual financial statements prepared in accordance
with U.S. GAAP.

In management’s opinion, the unaudited
interim condensed financial statements have been prepared on the same basis as the annual financial statements and reflect all adjustments,
which include only normal recurring adjustments necessary for the fair presentation of the Company’s financial position as of June
30, 2024, and the Company’s results of operations and cash flows for the six months ended June 30, 2024, and 2023. The results
for the six months ended June